Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Pancreatic Neoplasms × balstilimab × Clear all

Phase

Status

Recruiting 4 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Hemangiosarcoma 1 Fibrolamellar hepatocellular carcinoma 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 41 130-nm albumin-bound paclitaxel 25 Albumin-Bound Paclitaxel 18 Irinotecan 17 Oxaliplatin 15 Fluorouracil 15 pembrolizumab 13 Leucovorin 13 Taxes 11 Magnetic Resonance Spectroscopy 11 Nivolumab 10 Biopsy 8 Specimen Handling 7 Cisplatin 7 Carboplatin 6 irinotecan sucrosofate 5 folfirinox 5 durvalumab 5 Radiotherapy 5 dehydroftorafur 4 Paclitaxel 4 Ipilimumab 4 Cyclophosphamide 4 Capecitabine 4 defactinib 3 atezolizumab 3 Surveys and Questionnaires 3 Standard of Care 3 Practice Guidelines as Topic 3 Nutrition Assessment 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05638698 2024-09-23

TESLA

University of Kansas Medical Center

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡